Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Auzou N"" wg kryterium: Autor


Wyświetlanie 1-13 z 13
Tytuł :
Communicating chronic hydrocephalus: A review.
Autorzy :
Roblot P; Neurosurgery department A, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France; Laboratory of anatomy, university of Bordeaux, Bordeaux, France. Electronic address: .
Mollier O; Neurosurgery department B, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France.
Ollivier M; Department of diagnostic and therapeutic neuroimaging, Pellegrin hospital, place Amélie-Raba-Léon, 33000 Bordeaux, France.
Gallice T; Neurosurgery department B, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France; Department of critical care, Bordeaux university hospital, 33076 Bordeaux, France.
Planchon C; Neurosurgery department A, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France; Neurosurgery department B, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France.
Gimbert E; Neurosurgery department A, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France.
Danet M; Department of geriatric medicine, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France.
Renault S; Department of neurology, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France.
Auzou N; Institute for neurodegenerative diseases, CNRS UMR 5293, university Bordeaux, Bordeaux, France.
Laurens B; Department of neurology, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France; Institute for neurodegenerative diseases, CNRS UMR 5293, university Bordeaux, Bordeaux, France.
Jecko V; Neurosurgery department A, university hospital of Bordeaux, place Amélie-Raba-Léon, Bordeaux, France; Université de Bordeaux, CNRS UMR 5287, INCIA, Zone nord, Bat 2, 2e étage, 146, rue Léo-Saignat, 33076 Bordeaux cedex, France.
Pokaż więcej
Źródło :
La Revue de medecine interne [Rev Med Interne] 2021 Jun 15. Date of Electronic Publication: 2021 Jun 15.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Impact of Subthalamic Deep Brain Stimulation on Impulse Control Disorders in Parkinson's Disease: A Prospective Study.
Autorzy :
Santin MDN; Department of Neurosurgery, NS-PARK/F-CRIN, Strasbourg University Hospital, Strasbourg, France.
Voulleminot P; Department of Neurology, NS-PARK/F-CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France.
Vrillon A; Department of Neurology, NS-PARK/F-CRIN, Assistance Publique - Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, Paris, France.
Hainque E; Department of Neurology, NS-PARK/F-CRIN, Assistance Publique - Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, Paris, France.; Sorbonne Universités, Assistance Publique - Hôpitaux de Paris (APHP), Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM), Paris, France.
Béreau M; Department of Neurology, NS-PARK/F-CRIN, University Hospital of Besançon, Besançon, France.
Lagha-Boukbiza O; Department of Neurology, NS-PARK/F-CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France.
Wirth T; Department of Neurology, NS-PARK/F-CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France.
Montaut S; Department of Neurology, NS-PARK/F-CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France.
Bardinet E; Department of Neurology, NS-PARK/F-CRIN, University Hospital of Besançon, Besançon, France.; Centre de Neuroimagerie de Recherche, Institut du Cerveau et de la Moelle (ICM), Paris, France.
Kyheng M; Department of Clinical Research, Lille University Hospital, Lille, France.
Rolland AS; Department of Medical Pharmacology, University Hospital, NS-PARK/F-CRIN, University of Lille, Lille Neuroscience & Cognition, Inserm, UMR-S1172, Lille, France.
Voirin J; Department of Neurosurgery, NS-PARK/F-CRIN, Strasbourg University Hospital, Strasbourg, France.
Drapier S; Department of Neurology, NS-PARK/F-CRIN, University Hospital of Rennes, Rennes, France.
Durif F; Department of Neurology, NS-PARK/F-CRIN, CHU Clermont-Ferrand, Clermont-Ferrand, France.
Eusebio A; Department of Neurology, NS-PARK/F-CRIN, Assistance Publique - Hôpitaux de Marseille (APHM), Timone University Hospital and Institut de Neurosciences de la Timone, Marseille, France.
Giordana C; Department of Neurology, NS-PARK/F-CRIN, Centre Hospitalier Universitaire de Nice, Nice, France.
Auzou N; Institute of Neurodegenerative Disorders, NS-PARK/F-CRIN, University Hospital of Bordeaux, Bordeaux, France.
Houeto JL; Department of Neurology, NS-PARK/F-CRIN, University Hospital of Poitiers, Poitiers, France.
Hubsch C; Department of Neurology, NS-PARK/F-CRIN, Fondation Ophtalmologique Adolphe de Rothschild, Paris, France.
Jarraya B; Neuroscience Pole, NS-PARK/F-CRIN, Hôpital Foch, Suresnes, University of Versailles Paris-Saclay, INSERM-CEA NeuroSpin, Saclay, France.
Laurencin C; Department of Neurology, NS-PARK/F-CRIN, University Hospital of Lyon, Lyon, France.
Maltete D; Department of Neurology, NS-PARK/F-CRIN, Rouen University Hospital and University of Rouen, France; INSERM U1239, Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, Mont-Saint-Aignan, France.
Meyer M; Department of Neurology, NS-PARK/F-CRIN, University Hospital of Nancy, Nancy, France.
Rascol O; Department of Clinical Pharmacology and Neuroscience, NS-Park/F-CRIN, Toulouse University Hospital, Toulouse, France.
Rouaud T; Department of Neurology, NS-PARK/F-CRIN, Nantes University Hospital, Nantes, France.
Tir M; Department of Neurology, NS-PARK/FCRIN, Amiens University Hospital, Amiens, France.
Moreau C; Department of Neurology, University Hospital, NS-PARK/F-CRIN, University of Lille, Lille Neuroscience & Cognition, INSERM, UMR-S1172, Lille, France.
Corvol JC; Department of Neurology, NS-PARK/F-CRIN, Assistance Publique - Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, Paris, France.; Sorbonne Universités, Assistance Publique - Hôpitaux de Paris (APHP), Inserm, CNRS, Institut du Cerveau et de la Moelle (ICM), Paris, France.
Proust F; Department of Neurosurgery, NS-PARK/F-CRIN, Strasbourg University Hospital, Strasbourg, France.
Grabli D; Department of Neurology, NS-PARK/F-CRIN, Assistance Publique - Hôpitaux de Paris (APHP), Pitié-Salpêtrière Hospital, Paris, France.
Devos D; Department of Medical Pharmacology, University Hospital, NS-PARK/F-CRIN, University of Lille, Lille Neuroscience & Cognition, Inserm, UMR-S1172, Lille, France.; Department of Neurology, University Hospital, NS-PARK/F-CRIN, University of Lille, Lille Neuroscience & Cognition, INSERM, UMR-S1172, Lille, France.
Tranchant C; Department of Neurology, NS-PARK/F-CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France.
Anheim M; Department of Neurology, NS-PARK/F-CRIN, Strasbourg University Hospital, Fédération de Médecine Translationnelle de Médecine de Strasbourg, Strasbourg, France.
Pokaż więcej
Corporate Authors :
Predistim Study Group
Źródło :
Movement disorders : official journal of the Movement Disorder Society [Mov Disord] 2021 Mar; Vol. 36 (3), pp. 750-757. Date of Electronic Publication: 2020 Oct 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Deep Brain Stimulation*
Disruptive, Impulse Control, and Conduct Disorders*/etiology
Disruptive, Impulse Control, and Conduct Disorders*/therapy
Parkinson Disease*/complications
Parkinson Disease*/therapy
Follow-Up Studies ; Humans ; Prospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Personality dimensions of patients can change during the course of parkinson's disease.
Autorzy :
Boussac M; Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.
Arbus C; Psychiatry Department of the University Hospital of Toulouse, CHU Purpan, Toulouse, France.
Dupouy J; Department of Neurology, Hospital of Avignon, Avignon, France.
Harroch E; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, NS-PARK/FCRIN Network, Toulouse, France.
Rousseau V; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, NS-PARK/FCRIN Network, Toulouse, France.
Croiset A; CERPPS-Study and Research Center in Psychopathology and Health Psychology, University of Toulouse II Jean-Jaurès, Toulouse, France.
Ory-Magne F; Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, NS-PARK/FCRIN Network, Toulouse, France.
Rascol O; Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, NS-PARK/FCRIN Network, Toulouse, France.
Moreau C; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, Lille, France.
Rolland AS; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, Lille, France.
Maltête D; Department of Neurology, Rouen University Hospital and University of Rouen, Rouen, France.; Laboratory of Neuronal and Neuroendocrine Differentiation and Communication, INSERM U1239, NS-PARK/FCRIN Network, Mont-Saint-Aignan, France.
Rouaud T; Clinique Neurologique, Hôpital Guillaume et René Laennec, NS-PARK/FCRIN Network, Boulevard Jacques Monod, Nantes, France.
Meyer M; Neurology Department, Nancy University Hospital, Nancy, France.
Drapier S; Behavior and Basal Ganglia Research Unit (EA 4712), University of Rennes 1, Rennes, France.; Department of Neurology, Rennes University Hospital, NS-PARK/FCRIN Network, Rennes, France.
Giordana B; Service Universitaire de Psychiatrie, Hôpital Pasteur 1, CHU de Nice, Nice, France.
Anheim M; Service de Neurologie, Hôpitaux Universitaires de Strasbourg, Strasbourg, France.; Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), INSERM-U964/CNRS-UMR7104/Université de Strasbourg, Illkirch, France.; Fédération de Médecine Translationnelle de Strasbourg (FMTS), Université de Strasbourg, NS-PARK/FCRIN Network, Strasbourg, France.
Hainque E; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, Paris, France.
Jarraya B; Pôle Neurosciences, Foch Hospital, Suresnes, France.; Université de Versailles Paris-Saclay, INSERM U992, CEA Neurospin, France.
Benatru I; Service de Neurologie, Centre Expert Parkinson, CIC-INSERM 1402, CHU Poitiers, NS-PARK/FCRIN Network, Poitiers, France.
Auzou N; CHU de Bordeaux, Centre Expert Parkinson, Institut des maladies neuro-dégénératives, Bordeaux, France.
Belamri L; Hôpital Fondation A de Rothschild, Service de recherche clinique, Paris, France.
Tir M; Department of Neurology, Department of Neurosurgery, Expert Centre for Parkinson's disease, Amiens University Hospital, EA 4559 Laboratoire de Neurosciences Fonctionnelles et Pathologie (LNFP) Université de Picardie Jules Verne, University of Picardy Jules Verne (UPJV), NS-PARK/FCRIN Network, Amiens, France.
Marques AR; Neurology Department, Université Clermont Auvergne, EA7280, Clermont-Ferrand University Hospital, NS-PARK/FCRIN Network, Clermont-Ferrand, France.
Thobois S; Univ Lyon, Université Claude Bernard Lyon 1, Faculté de Médecine Lyon Sud Charles Mérieux, Lyon, France.; CNRS, Institut des Sciences Cognitives, UMR 5229, Bron, France.; Centre Expert Parkinson, Hôpital Neurologique 'Pierre Wertheimer', Hospices Civils de Lyon, NS-PARK/FCRIN Network, Lyon, France.
Eusebio A; Aix Marseille Université, AP-HM, Hôpital de La Timone, Service de Neurologie et Pathologie du Mouvement, and UMR CNRS 7289, Institut de Neuroscience de La Timone, NS-PARK/FCRIN Network, Marseille, France.
Corvol JC; Département de Neurologie, Hôpital Pitié-Salpêtrière, AP-HP, Faculté de Médecine de Sorbonne Université, UMR S 1127, Inserm U 1127, and CNRS UMR 7225, and Institut du Cerveau et de la Moëlle épinière, NS-PARK/FCRIN Network, Paris, France.
Devos D; Department of Medical Pharmacology, Neurology and Movement Disorders Department, Referent Center of Parkinson's disease, CHU of Lille, Univ. Lille Neuroscience & Cognition, Inserm, UMR-S1172, Licend, NS-PARK/FCRIN Network, Lille, France.
Brefel-Courbon C; Toulouse NeuroImaging Center, University of Toulouse, Inserm, UPS, Toulouse, France.; Department of Clinical Pharmacology and Neurosciences, Parkinson Expert Center, Centre d'Investigation Clinique CIC1436, University Hospital of Toulouse, NeuroToul COEN Center, NS-PARK/FCRIN Network, Toulouse, France.
Pokaż więcej
Corporate Authors :
PREDI-STIM study group
Źródło :
PloS one [PLoS One] 2021 Jan 07; Vol. 16 (1), pp. e0245142. Date of Electronic Publication: 2021 Jan 07 (Print Publication: 2021).
Typ publikacji :
Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Character*
Parkinson Disease/*psychology
Personality Disorders/*psychology
Aged ; Female ; Humans ; Male ; Middle Aged ; Personality Inventory
Czasopismo naukowe
Tytuł :
A Phase 2 Randomized Trial of Asleep versus Awake Subthalamic Nucleus Deep Brain Stimulation for Parkinson's Disease.
Autorzy :
Engelhardt J; CHU de Bordeaux, Service de Neurochirurgie B, Bordeaux, France, .; Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France, .; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France, .
Caire F; Université de Limoges, CNRS, XLIM, UMR7252, Limoges, France.; CHU de Limoges, Service de Neurochirurgie, Limoges, France.
Damon-Perrière N; Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.; CHU de Bordeaux, Service d'explorations Fonctionnelles du Système Nerveux, Bordeaux, France.
Guehl D; Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.; CHU de Bordeaux, Service d'explorations Fonctionnelles du Système Nerveux, Bordeaux, France.
Branchard O; CHU de Bordeaux, Service de Neurochirurgie B, Bordeaux, France.
Auzou N; CHU de Bordeaux, Service de Neurologie, Bordeaux, France.; Laboratoire de Psychologie, Université de Bordeaux, Bordeaux, France.
Tison F; Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.; CHU de Bordeaux, Service de Neurologie, Bordeaux, France.
Meissner WG; Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.; CHU de Bordeaux, Service de Neurologie, Bordeaux, France.
Krim E; CH de Pau, Service de Neurologie, Pau, France.
Bannier S; CH de Bayonne, Service de Neurologie, Bayonne, France.
Bénard A; CHU Bordeaux, Pôle de Santé Publique, Clinical Epidemiology Unit (USMR), Bordeaux, France.
Sitta R; CHU Bordeaux, Pôle de Santé Publique, Clinical Epidemiology Unit (USMR), Bordeaux, France.
Fontaine D; CHU de Nice, Service de Neurochirurgie, Nice, France.; Université Côte d'Azur, Nice, France.
Hoarau X; Polyclinique de Navarre, Service de Neurochirurgie, Pau, France.
Burbaud P; Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.; CHU de Bordeaux, Service d'explorations Fonctionnelles du Système Nerveux, Bordeaux, France.
Cuny E; CHU de Bordeaux, Service de Neurochirurgie B, Bordeaux, France.; Institut des Maladies Neurodégénératives, Université de Bordeaux, UMR 5293, Bordeaux, France.; CNRS, Institut des Maladies Neurodégénératives, UMR 5293, Bordeaux, France.
Pokaż więcej
Źródło :
Stereotactic and functional neurosurgery [Stereotact Funct Neurosurg] 2021; Vol. 99 (3), pp. 230-240. Date of Electronic Publication: 2020 Nov 30.
Typ publikacji :
Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Deep Brain Stimulation*
Parkinson Disease*/therapy
Subthalamic Nucleus*
Surgery, Computer-Assisted*
Humans ; Imaging, Three-Dimensional ; Prospective Studies ; Tomography, X-Ray Computed ; Treatment Outcome ; Wakefulness
Czasopismo naukowe
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies